New blood test can detect genes that drive cancer and help to determine best treatment

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2825 (Published 1 May 2013)
Cite this as: BMJ 2013;346:f2825

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Zosia Kmietowicz
  1. 1BMJ

Researchers have developed a new blood test that they say could be used to identify women whose breast cancer was being driven by the HER2 gene and who could benefit from treatment with trastuzumab (Herceptin) and similar drugs. They believe that the test could be adapted to a range of other cancers and drug targets.

At the moment women whose breast cancer relapses after initial treatment need to have a biopsy to determine which treatments the cancer is most likely to respond to. But cancers can acquire and lose genes over time, and …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL